FLT3 and leukemia: It displays potent anti-cancer activity in models of FLT3-driven AML and considerable inhibitory ability to leukemia stem-like cells or leukemia-initiating cells (LICs) in Hoechst side population (SP) assays and long-term culture initiating cell (LTC-IC) assays.